Rhumbline Advisers Immutep LTD Transaction History
Rhumbline Advisers
- $113 Billion
- Q2 2025
A detailed history of Rhumbline Advisers transactions in Immutep LTD stock. As of the latest transaction made, Rhumbline Advisers holds 26,717 shares of IMMP stock, worth $53,166. This represents 0.0% of its overall portfolio holdings.
Number of Shares
26,717
Previous 27,449
2.67%
Holding current value
$53,166
Previous $48,000
10.42%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding IMMP
# of Institutions
30Shares Held
1.92MCall Options Held
19.3KPut Options Held
27.3K-
Black Rock Inc. New York, NY839KShares$1.67 Million0.0% of portfolio
-
Meridian Wealth Management, LLC373KShares$741,6730.03% of portfolio
-
Sender CO & Partners, Inc. New York, NY123KShares$244,2800.11% of portfolio
-
Morgan Stanley New York, NY119KShares$237,7370.0% of portfolio
-
Ubs Group Ag64.8KShares$129,0350.0% of portfolio
About IMMUTEP Ltd
- Ticker IMMP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 86,624,000
- Market Cap $172M
- Description
- Immutep Limited, a biotechnology company, engages in the research and development of pharmaceutical product candidates. The company develops immunotherapeutic products for the treatment of cancer and autoimmune diseases. Its lead product candidate is eftilagimod alpha (efti or IMP321), a recombinant protein that is in Phase IIb clinical trial as...